The latest news: Medicare proposal to cover Optune for Glioblastoma We need to fight this. I will provide details next week! Brain Tumor Awareness Month 2019 Webinar Series! 2 webinars in the next few days! We have one this Sunday and Wednesday! Both have excellent speakers. Sunday is on Immunotherapies, Wednesday is on Onc-201 for DIPG and H3K27M mutant gliomas. New Treatment Could Become First Targeted Therapy Designed For ‘Untreatable’ Childhood Brain Cancer This is very early but it is an exciting new type of treatment for dipg. The Musella Foundation is part of the DIPG Collaborative and helped fund this project! Oncoceutics Invited to Present ONC201 at Public Advisory Committee Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee on June 20, 2019 This is exciting for the drug Onc-201. The meeting is not for approval but for the FDA to learn about the drug and help guide the process to approval. This is not done for most drugs. Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System This may be the missing link in understanding how the immune system fights cancer and why checkpoint inhibitors do not allwas work. Excellent research and I hope someone tests this in brain tumors. The EndBrainCancer Initiative to Feature Renowned Brain Cancer and Modified Poliovirus Duke Researcher, Dr. Annick Desjardins, as its Keynote Speaker for the 2019 Annual May "Brains Matter" ACTION Dinner From our good friends at the End Brain Cancer Initiative, Should be interesting. BrainTumor Co-Payment Assistance Program Status: CLOSED to new applicants
